Private Equity Growth Adare Pharma Solutions is a private equity backed CDMO with a track record of growth since its 2020 acquisition by THL and Frazier Healthcare Partners, signaling long-term investment in capacity and capabilities. This ownership structure can support extended outsourcing commitments and scalable manufacturing partnerships for growing drug portfolios.

US Manufacturing Footprint Headquartered in Lawrenceville, New Jersey, the company offers a domestic US manufacturing option with regulatory alignment and supply-chain resilience for North American customers or partners seeking onshore production and faster time-to-market.

Advanced Tech Focus Positioned as a specialty CDMO with advanced pharmaceutical technologies, the company can partner on development and manufacturing programs requiring specialized capabilities, complex chemistries, and regulatory support across multiple modalities.

Scale Up Capabilities Past expansion activity including headcount growth and capital investments demonstrates the capacity and willingness to invest in new equipment and processes, making them suitable for customers with accelerating manufacturing needs or late-stage scale-up.

Mid Market Fit With revenue in the mid hundreds of millions and a mid-sized employee base, the company sits in the mid-market CDMO space ideal for mid-sized pharma and biotech clients seeking flexible outsourcing, risk sharing, and potential multi-site manufacturing partnerships.